The short answer
Chlorothiazide can raise blood calcium, so vitamin D supplementation needs review, particularly at high doses or with other calcium-raising treatments. This does not mean everyone must avoid vitamin D.
What this answer covers
Oral chlorothiazide with supplemental vitamin D2 or D3; active calcitriol and topical analogs are different exposures.
- Supplement or preparation
- Vitamin D
- Medication ingredient
- chlorothiazide
The basis for the concern
The oral chlorothiazide label describes reduced urinary calcium and sometimes slightly higher blood calcium. Marked elevations can signal an underlying parathyroid problem. Vitamin D can increase calcium absorption, adding a reason to review combined use.
A direct experiment showed different responses
In a small intravenous chlorothiazide study, calcium rose transiently in people with normal parathyroid function and more persistently in two with excess parathyroid activity. Six hypoparathyroid patients taking vitamin D2 had no calcium rise during chlorothiazide alone.
Why that is not an oral safety threshold
The experiment lasted hours, used an infusion and replaced urinary sodium and water losses. It does not predict long-term oral chlorothiazide with a particular supplement dose. The different responses also argue against assuming every patient develops high calcium.
Review intake and monitoring
Show the clinician all calcium, vitamin D and antacid products. Kidney function, parathyroid status and existing calcium results help guide use and monitoring. No reviewed evidence establishes a protective gap between doses or routine avoidance for everyone; do not stop prescribed supplements or chlorothiazide yourself.
Evidence and practical considerations
Timing & monitoring
No universal avoidance or protective spacing interval demonstrated. A narrower intake, preparation and clinical monitoring precaution may be appropriate.
- Exact scope
- Oral chlorothiazide with supplemental vitamin D2 or D3; active calcitriol and topical analogs are different exposures. with Oral chlorothiazide, exact RxCUI2396 IN. No automatic transfer from loop diuretics or another thiazide.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No universal risk rate or spacing interval; individual source limitations apply.
Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People treated with oral chlorothiazide
Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eight normal-parathyroid subjects, six hypoparathyroid and two hyperparathyroid patients.
Transient calcium rise in normal-parathyroid subjects, sustained rise in two hyperparathyroid patients, and no calcium rise during chlorothiazide alone in six vitamin-D-treated hypoparathyroid patients. No significant serum sodium or potassium change under replacement conditions.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Small acute experiment, not routine oral therapy or chronic supplement safety. Replacement protocol changes electrolyte interpretation; do not extrapolate urinary-calcium effects to chronic oral use.
Source 3: regulatory guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of the specified product
Thiazides reduce urinary calcium and vitamin D increases intestinal calcium absorption; the combination can increase hypercalcemia concern, especially with age, kidney impairment or hyperparathyroidism.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Class-level precaution, not a universal incidence or exact dose threshold for either drug.
Research assessment: · Open full citations ↗
Side effects & toxicity
Conditional calcium-elevation concern supported by exact medication evidence, with different-route or mixed-exposure limits and contrary/null human results. No universal dose threshold.
- Exact scope
- Oral chlorothiazide with supplemental vitamin D2 or D3; active calcitriol and topical analogs are different exposures. with Oral chlorothiazide, exact RxCUI2396 IN. No automatic transfer from loop diuretics or another thiazide.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- No universal risk rate or spacing interval; individual source limitations apply.
Factors that may matter: Preparation and plant part; Dose and duration; Kidney function; Fluid status; Other medicines; Calcium or potassium status.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People treated with oral chlorothiazide
Can cause fluid and electrolyte disturbances, including low potassium and sodium. Reduces urinary calcium excretion and can raise serum calcium; substantial elevation needs evaluation.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Exact oral product; not another thiazide or loop diuretic. Chlorothiazide sodium intravenous therapy is a separate route and salt. THALITONE has product-specific bioavailability and should not be assumed dose-for-dose identical to other formulations.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eight normal-parathyroid subjects, six hypoparathyroid and two hyperparathyroid patients.
Transient calcium rise in normal-parathyroid subjects, sustained rise in two hyperparathyroid patients, and no calcium rise during chlorothiazide alone in six vitamin-D-treated hypoparathyroid patients. No significant serum sodium or potassium change under replacement conditions.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Small acute experiment, not routine oral therapy or chronic supplement safety. Replacement protocol changes electrolyte interpretation; do not extrapolate urinary-calcium effects to chronic oral use.
Source 3: regulatory guidance
ods.od.nih.gov · Source check Sep 10, 2026
Population: Users of the specified product
Thiazides reduce urinary calcium and vitamin D increases intestinal calcium absorption; the combination can increase hypercalcemia concern, especially with age, kidney impairment or hyperparathyroidism.
How this applies: Exact medication, salt, route, plant part, formulation and clinical endpoint govern applicability.
Class-level precaution, not a universal incidence or exact dose threshold for either drug.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact-pair article with separately verified drug label, original human evidence and explicit preparation and endpoint limitations. | |
| Research summary published |
Article revision: ea63ef6f91c36d45
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.